Condition: Vulvovaginal Candidiases · Vulvovaginal Candidiasis, Genital · Vulvovaginal Candidiasis (VVC) · Sponsor: pH-D Feminine Health LLC
This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
This description comes directly from the study's public registry record.
Clinical Trial Manager · 513-709-4442 · s.sammons@medpace.com
Always discuss trial participation with your own doctor first.
| Alliance for Multispecialty Research - Mobile | Mobile, Alabama, United States | Recruiting |
| Abby's Research Institute | Phoenix, Arizona, United States | Withdrawn |
| Applied Research Center of Arkansas Inc. | Little Rock, Arkansas, United States | Recruiting |
| Century Research Institute, Inc | Huntington Park, California, United States | Active Not Recruiting |
| Matrix Clinical Research | Los Angeles, California, United States | Recruiting |
| M3 Wake Research - San Diego | San Diego, California, United States | Recruiting |
| Integrated Clinical Research LLC | Sherman Oaks, California, United States | Recruiting |
| Project 4 Research Inc | Miami, Florida, United States | Recruiting |
| Entrust Clinical Research | Miami, Florida, United States | Recruiting |
| Felicidad Medical Research, LLC | Miami, Florida, United States | Recruiting |
| Better Life Clinical Research, LLC | Tampa, Florida, United States | Recruiting |
| Helping Hands Health Center | Tampa, Florida, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07109869